Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research.
Kerschbaumer A, Smolen JS, Nash P, Doerner T, Dougados M, Fleischmann R, Geissler K, McInnes IB, Takeuchi T, Trauner M, Winthrop K, de Wit M, Boehncke WH, Falzon L, van der Heijde D.
Kerschbaumer A, et al. Among authors: falzon l.
RMD Open. 2020 Nov;6(3):e001374. doi: 10.1136/rmdopen-2020-001374.
RMD Open. 2020.
PMID: 33188136
Free PMC article.